SCHEMBL5252111

SCHEMBL5252111

COC(=O)N(CC(=O)O)C(C(=O)O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TSHR P16473 1/20 0.41
NR1H2 P55055 2/20 0.40
NR1H3 Q13133 2/20 0.40
ROCK2 O75116 1/20 0.40
PPARA Q07869 3/20 0.39
PPARG P37231 2/20 0.39
NR4A2 P43354 1/20 0.39
APAF1 O14727 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP2D6 P10635 1/20 0.37
SRC P12931 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8749590 0.85 ALDH1A1 (0.46) KMT2AALDH1A1L3MBTL1TSHRNR1H2
SCHEMBL6120907 0.85 ALDH1A1 (0.46) KMT2AALDH1A1L3MBTL1TSHRNR1H2
SCHEMBL5255513 0.83 CASR (0.43) KMT2AALDH1A1L3MBTL1TSHRNR1H2
SCHEMBL18586587 0.81 CYP2D6 (0.43) ALDH1A1TSHRNR1H2NR1H3NR4A2
SCHEMBL4693729 0.80 LMNA (0.39) KMT2AALDH1A1L3MBTL1TSHRSMN1; SMN2
SCHEMBL19772673 0.78 KMT2A (0.47) KMT2AALDH1A1L3MBTL1TSHRROCK2
SCHEMBL20348009 0.78 KMT2A (0.47) KMT2AALDH1A1L3MBTL1TSHRROCK2
SCHEMBL17702833 0.78 KMT2A (0.47) KMT2AALDH1A1TSHRROCK2NR4A2
SCHEMBL18931320 0.74 KMT2A (0.43) KMT2AALDH1A1L3MBTL1TSHRNR1H2
SCHEMBL5185704 0.73 KMT2A (0.43) KMT2AL3MBTL1NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1798231-A2 Intermediate products for the preparation of antibacterial compounds NOVEXEL (FR) 2007-06-20 EP disclosed
EP-1399444-B1 NOVEL HETEROCYCLIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINES, IN PARTICULAR AS ANTI-BACTERIAL AGENTS NOVEXEL (FR) 2007-04-11 EP disclosed